DTU
DTU

Atorvastatin in Factorial with Omega-3 Fatty Acids Risk Reduction in Diabetes

Conference abstracts (3 of 3)

Years :

Search conference abstracts :

2006

Diabetes UK Annual Professional Conference, Birmingham
LDL cholesterol levels alone do not adequately assess coronary heart disease risk in Type 2 diabetes
Farmer AJ, Paul S, Stratton IM, Tucker L, Neil HAW, Holman RR
Diabetic Medicine 2006;23:Suppl 2:89
[Abstract]

66th Scientific Session of the American Diabetes Association, Washington
LDL Cholesterol Level Alone does not Assess Coronary Heart Disease Risk Adequately in Type 2 Diabetes
Farmer AJ, Paul SK, Stratton IM, Tucker L, Neil AW and Holman RR
Diabetes 2006;55:Suppl 1:A462
[Abstract]

2005

Diabetes UK Annual Professional Conference, Glasgow
AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids
Farmer AJ,Neil HAW, Holman RR
Diabetic Medicine 2005;22:S2:63
[Abstract]